Cargando…
The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers
SIMPLE SUMMARY: Cancer of the stomach, esophagus and colon are often fatal. Ways are being sought to establish patient-friendly screening tests that would allow these cancers to be detected earlier. Examination of the metabolomics results of cancer patient’s serum for certain metabolites unique for...
Autores principales: | Ren, Zhenxing, Rajani, Cynthia, Jia, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916516/ https://www.ncbi.nlm.nih.gov/pubmed/33578739 http://dx.doi.org/10.3390/cancers13040720 |
Ejemplares similares
-
Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
por: Jia, Wei, et al.
Publicado: (2020) -
Viral Infection in Esophageal, Gastric, and Colorectal Cancer
por: Yamashina, Takeshi, et al.
Publicado: (2022) -
Global serum metabolomics profiling of colorectal cancer
por: Hashim, Nurul Azmir Amir, et al.
Publicado: (2019) -
A systematic review of metabolomic profiling of gastric cancer and esophageal cancer
por: Huang, Sha, et al.
Publicado: (2020) -
The Role of Peroxisome Proliferator-Activated Receptors in the Esophageal, Gastric, and Colorectal Cancer
por: Fucci, Alessandra, et al.
Publicado: (2012)